Bio-Path Holdings Inc (NASDAQ:BPTH)’s traded shares stood at 0.49 million during the last session, with the company’s beta value hitting 0.16. At the close of trading, the stock’s price was $1.14, to imply a decrease of -15.56% or -$0.21 in intraday trading. The BPTH share’s 52-week high remains $12.00, putting it -952.63% down since that peak but still an impressive 48.25% since price per share fell to its 52-week low of $0.59. The company has a valuation of $4.91M, with an average of 12.18 million shares in intraday trading volume over the past 10 days and average of 3.12 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Bio-Path Holdings Inc (BPTH), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give BPTH a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.37.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bio-Path Holdings Inc (NASDAQ:BPTH) trade information
After registering a -15.56% downside in the last session, Bio-Path Holdings Inc (BPTH) has traded red over the past five days. The 5-day price performance for the stock is -23.49%, and 41.70% over 30 days. With these gigs, the year-to-date price performance is -87.69%. Short interest in Bio-Path Holdings Inc (NASDAQ:BPTH) saw shorts transact 77764.0 shares and set a 0.03 days time to cover.
Bio-Path Holdings Inc (BPTH) estimates and forecasts
Looking at statistics comparing Bio-Path Holdings Inc share performance against respective industry, we note that the company has outperformed competitors. Bio-Path Holdings Inc (BPTH) shares are -43.00% down over the last 6 months, with its year-to-date growth rate higher than industry average at 90.57% against 16.40%.
BPTH Dividends
Bio-Path Holdings Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Bio-Path Holdings Inc (NASDAQ:BPTH)’s Major holders
Bio-Path Holdings Inc insiders hold 0.04% of total outstanding shares, with institutional holders owning 1.08% of the shares at 1.08% float percentage. In total, 1.08% institutions holds shares in the company.
We also have Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Bio-Path Holdings Inc (BPTH) shares. Going by data provided on Sep 30, 2024 , Vanguard Extended Market Index Fund holds roughly 13.5 shares. This is just over 0.31% of the total shares, with a market valuation of $15392.0. Data from the same date shows that the other fund manager holds a little less at 11.96, or 0.28% of the shares, all valued at about 13637.0.
